Practice question

Answer the question and get instant feedback.

Easy"ADA Standards of Care (2025): Pharmacologic Approaches to Glycaemic Treatment"T2D (hypoglycaemia risk)"t2d (hypoglycaemia risk)"

A 66-year-old with T2D and recurrent hypoglycaemia on sulfonylurea asks about alternatives. Per ADA 2025, the preferred switch to reduce hypoglycaemia risk is:

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.